Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

The future of medicine is being quietly built in an unassuming Perth lab by an impressive group that is flying under the ...

With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.

Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...

John Crowley, Biotechnology Innovation Organization (BIO) president and CEO, joins 'Squawk Box' to discuss 50 years of ...

At the Texas Medical Center—the largest medical complex in the world—the future of medicine is not only being developed in ...

AV Laboratories is redefining the future of skincare by translating decades of advanced biotechnology research into clinically driven formulations designed for everyday use. Rooted in expertise ...

In this episode of Denatured, you'll be hearing from Edoardo Negroni, co-founder & managing partner at AurorA-TT and Naveed ...

Virtual event highlights cutting‑edge innovations driving advances in healthcare, sustainability, and emerging ...

The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

Nuevocor, a biotechnology company that develops therapies for cardiomyopathies, has appointed Monica Shah, MD, as chief medical officer.  Dr. Shah is a heart failure and transplant cardiologist with ...